Burning mouth syndrome: review of etiopathogenetic factors and update on clinical management strategies

This study focuses on the possible etiopathogenetic mechanisms underlying burning mouth syndrome and the most appropriate clinical management for its treatment. Burning Mouth Syndrome (BMS) is characterized by an intraoral burning sensation or dysesthesia without any detectable alterations in the oral mucosa, causing significant discomfort in affected patients. The idiopathic nature of that type of chronic orofacial pain makes it challenging to identify specific etiopathogenetic factors and mechanisms. Therefore, the therapeutic strategy for BMS is challenging to choose among, including pharmacological approaches involving synthetic drugs or compounds derived from natural substances. The most appropriate clinical management for its treatment may involve different therapeutic approaches, although a definitive protocol for managing BMS has yet to be established.

Authors

Institutions

Publication Details

Journal
Oral & Implantology
Published
2025-02-12
DOI
https://doi.org/10.11138/oi.v17i1.118
Primary Topic
Salivary Gland Disorders and Functions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Burning mouth syndrome: review of etiopathogenetic factors and update on clinical management strategies

Graziella Alebrant Mendes, Davide Gerardi, Maurizio Piattelli, Fabiola Rinaldi et al.
Oral & Implantology
Salivary Gland Disorders and Functions
article

Burning mouth syndrome: review of etiopathogenetic factors and update on clinical management strategies

Graziella Alebrant Mendes, Davide Gerardi, Maurizio Piattelli, Fabiola Rinaldi, Giuseppe Varvara, Francesca Angiolani, Pierangelo Burdo
article en

Abstract

This study focuses on the possible etiopathogenetic mechanisms underlying burning mouth syndrome and the most appropriate clinical management for its treatment. Burning Mouth Syndrome (BMS) is characterized by an intraoral burning sensation or dysesthesia without any detectable alterations in the oral mucosa, causing significant discomfort in affected patients. The idiopathic nature of that type of chronic orofacial pain makes it challenging to identify specific etiopathogenetic factors and mechanisms. Therefore, the therapeutic strategy for BMS is challenging to choose among, including pharmacological approaches involving synthetic drugs or compounds derived from natural substances. The most appropriate clinical management for its treatment may involve different therapeutic approaches, although a definitive protocol for managing BMS has yet to be established.

Oral & ImplantologyVol. 17(1)
University of L'Aquila (IT), University of Chieti-Pescara (IT), Universidade Metropolitana de Santos (BR)
Openalex Percentile: Top 96%
Salivary Gland Disorders and Functions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.